Clinical Trials Logo

hATTR Amyloidosis clinical trials

View clinical trials related to hATTR Amyloidosis.

Filter by:
  • None
  • Page 1

NCT ID: NCT06040567 Recruiting - Clinical trials for Diabetic Polyneuropathy

Polyneuropathy, Impairments and Physical Activity - The PolyImPAct Study

PolyImPAct
Start date: September 23, 2023
Phase:
Study type: Observational

The project aims to investigate the validity, and reliability of outcome measures of muscle strength, functioning (gait, balance, and fine motor skills), physical activity, and patient-reported outcome measures of functioning (gait, balance, and fine motor skills), and daily living among patients with polyneuropathy. Further, the project aims to compare physical activity and patient-reported outcome measures of functioning (gait, balance, and fine motor skills), and daily living among patients with polyneuropathy with physical activity and patient-reported outcome measures of functioning (gait, balance, and fine motor skills) and daily living in healthy adults.

NCT ID: NCT03728634 Completed - Healthy Volunteers Clinical Trials

Evaluate the Safety and Tolerability, as Well as the Pharmacokinetic and Pharmacodynamic Profiles of Single and Multiple Doses of Eplontersen Administered Subcutaneously to Healthy Volunteers and Patients With Hereditary Transthyretin-Mediated Amyloidosis (hATTR ).

Start date: December 21, 2018
Phase: Phase 1/Phase 2
Study type: Interventional

To evaluate the safety and tolerability, as well as the pharmacokinetic and pharmacodynamic profiles of single and multiple doses of Eplontersen administered subcutaneously to healthy volunteers and patients with Hereditary Transthyretin-Mediated Amyloidosis (hATTR ).